News of the WeekMedicine

Disrupting Hedgehog May Reverse Advanced Cancer, If Only Temporarily

See allHide authors and affiliations

Science  04 Sep 2009:
Vol. 325, Issue 5945, pp. 1188
DOI: 10.1126/science.325_1188

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

In the first clinical proof of its kind, a drug has dramatically shrunk cancerous tumors by disrupting a key genetic pathway. But a study targeting one deadly brain cancer, medulloblastoma, ended in disappointment as the patient's once-tamed tumor quickly developed resistance to the drug and killed him. A separate study published online this week in Science describes the mechanism by which the man's brain tumor developed resistance.